Fedme

Scientists have developed a hybrid obesity treatment that uses GLP-1 and GIP signals to deliver a metabolic enhancer directly into cells. Early tests in mice showed greater weight loss and better blood sugar control than standard therapies. The approach aims to reduce side effects by limiting the drug's action to targeted areas.

25. april 2026 Rapporteret af AI

Young Indians are turning to diabetes drugs Ozempic and Mounjaro for rapid weight loss before weddings and job interviews, as experts warn of cosmetic misuse, grey market dangers, and rising lookism. These GLP-1 drugs are meant for obesity and diabetes, not vanity purposes, doctors emphasize.

Researchers report that a protein signal called SLIT3 helps brown fat ramp up heat production by coordinating the growth of blood vessels and sympathetic nerves. In experiments using mouse models and human cells and tissue datasets, the team found SLIT3 is cut into two fragments with distinct roles—one linked to vessel growth and the other to nerve expansion—pointing to possible future obesity-treatment strategies aimed at boosting energy expenditure.

23. marts 2026 Rapporteret af AI

Et nyt studie fra Karolinska Institutet viser, at børn med moderat overvægt har en højere risiko for type 2-diabetes, forhøjet blodtryk og forstyrrelser i fedtstofferne i voksenlivet, selv uden tydelige risikomarkører. Forskerne opfordrer til behandling af alle børn i denne gruppe.

Researchers from the University of Bonn analyzed the Asian financial crisis's impact on Indonesian children, finding that soaring rice prices led to stunted growth and later obesity risks. The study, based on long-term household data, highlights how families cut nutrient-rich foods during crises. Effects were strongest in urban areas and low-education households.

6. marts 2026 Rapporteret af AI

Experts in India are urging the recognition of abdominal obesity as a new vital sign in Asian Indians to better assess metabolic health risks. An editorial by Amerta Ghosh and Anoop Misra emphasizes the need to measure waist circumference in all patients. This shift addresses the limitations of BMI as a measure of obesity.